Ignite Creation Date:
2024-05-06 @ 5:46 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05425719
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2022-04-21
Brief Title:
Pharmacokinetics and Safety of MB-102 Relmapirazin and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
Sponsor:
MediBeacon
Organization:
MediBeacon
Organization Data
Organization:
MediBeacon
Class:
INDUSTRY
Study ID:
MB-100-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MediBeacon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None